• about axogen
    • management team
    • board of directors
    • careers
    • partners
    • grants, donations, and sponsorships
    • code of ethics and conduct
    • patents
  • investors
  • news
  • contact
    • find a rep
    • international distributors
    • find referring surgeon
  • healthcare professionals
  • patients
Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Info
    • Contacts
    • FAQ
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

AxoGen, Inc. Announces 2015 Annual Shareholders’ Meeting

Apr 27, 2015

"Women's Radio Network Open Forum" To Feature AxoGen, Inc. CMO Jill Schiaparelli Discussing Women Suffering from Nerve Injuries and Options for Repair

Apr 23, 2015

AxoGen, Inc. to Report First Quarter Financial Results on May 5, 2015

Apr 21, 2015

AxoGen, Inc. to Participate in American Academy of Orthopedic Surgeons (AAOS) 2015 Annual Meeting

Mar 23, 2015

AxoGen, Inc. CEO Karen Zaderej to Discuss AxoGen's Growth, Nerve Injuries and New Options for Nerve Repair on "The Big Biz Show"

Mar 19, 2015

AxoGen, Inc. to Present at Canaccord Genuity’s Musculoskeletal Conference

Mar 16, 2015

AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter

Mar 5, 2015

AxoGen, Inc. to Report Fourth Quarter and Full Year Financial Results on March 5, 2015

Feb 26, 2015

AxoGen, Inc. Announces Presentation of Additional Clinical Data For Avance® Nerve Graft

Feb 25, 2015

AxoGen, Inc. Announces Closing of Public Offering of Common Stock

Feb 10, 2015
RSS
    • 1...
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    • ...35
    Next

    13631 Progress Blvd, Suite 400
    Alachua, FL 32615

    • contact
    • careers
    • Privacy Policy
    • Terms and Conditions
    • Website Terms of Use
    • Legal Notices
    • Instagram Logo
    • Twitter Logo
    • Linkedin Logo
    • Facebook Logo

    © 2025 Axogen Corporation. The stylized "a" logo and Avance Nerve Graft are registered trademarks of Axogen Corporation.

    Top

    You are now leaving axogeninc.com

    Axogen is not responsible for content or policies on linked sites.